Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders
文献类型:期刊论文
作者 | Kong, Qingyan1,2; Han, Buxin1,2,3![]() |
刊名 | EXPERT REVIEW OF NEUROTHERAPEUTICS
![]() |
出版日期 | 2024-05-03 |
卷号 | 24期号:5页码:517-525 |
通讯作者邮箱 | hanbx@psych.ac.cn (buxin han) |
关键词 | Anxiety disorders cognitive bias modification Chinese culture pharmacotherapy treatment |
ISSN号 | 1473-7175 |
DOI | 10.1080/14737175.2024.2334847 |
产权排序 | 1 |
文献子类 | 综述 |
英文摘要 | IntroductionAnxiety disorders are characterized by widespread and persistent anxiety or recurrent panic attacks. As a result of their high prevalence, chronicity, and comorbidity, patients' quality of life and functioning are severely compromised. However, several patients do not receive treatment.Areas coveredThis review discusses the effectiveness, safety, and limitations of major medications and cognitive bias modification (CBM) for treating anxiety disorders. The possibility of combined treatment is also discussed in the literature. Furthermore, drawing on Chinese cultural perspectives, the authors suggest that anxiety can be recognized, measured, and coped with at three levels of skill (), vision (), and Tao ().Expert opinionThe combination of pharmacotherapy and CBM is possibly more effective in treating anxiety disorders than either treatment alone. However, clinicians and patients should participate in the joint decision-making process and consider comprehensive factors. Moderate anxiety has adaptive significance. In the coming years, by combining the downward analytical system of western culture with the upward integrative system of Chinese culture, a comprehensive understanding of anxiety and anxiety disorders should be established, rather than focusing only on their treatment. |
收录类别 | SCI |
WOS关键词 | SOCIAL ANXIETY ; PREGABALIN ; EFFICACY ; ATTENTION ; CARE ; COMORBIDITY ; FEAR ; PHARMACOLOGY ; PREVALENCE ; RECURRENCE |
资助项目 | Social Science Foundation of China[20VYJ041] |
WOS研究方向 | Neurosciences & Neurology ; Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:001195013400001 |
出版者 | TAYLOR & FRANCIS LTD |
资助机构 | Social Science Foundation of China |
源URL | [http://ir.psych.ac.cn/handle/311026/47546] ![]() |
专题 | 心理研究所_中国科学院心理健康重点实验室 |
通讯作者 | Han, Buxin |
作者单位 | 1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China 2.Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China 3.Chinese Acad Sci, Inst Psychol, 16 Lincui Rd, Beijing 100101, Peoples R China |
推荐引用方式 GB/T 7714 | Kong, Qingyan,Han, Buxin. Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS,2024,24(5):517-525. |
APA | Kong, Qingyan,&Han, Buxin.(2024).Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders.EXPERT REVIEW OF NEUROTHERAPEUTICS,24(5),517-525. |
MLA | Kong, Qingyan,et al."Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders".EXPERT REVIEW OF NEUROTHERAPEUTICS 24.5(2024):517-525. |
入库方式: OAI收割
来源:心理研究所
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。